34 results
F-3
EX-5.1
AUTL
Autolus Therapeutics plc
3 May 22
Shelf registration (foreign)
7:25pm
to the Relevant Agreements will at all relevant times remain, in compliance with all applicable anti-corruption, anti-money laundering, anti-terrorism
S-3ASR
EX-5.1
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
is, and the Company and each party to the Relevant Agreements will at all relevant times remain, in compliance with all applicable anti-corruption, anti
F-3
EX-5.1
AUTL
Autolus Therapeutics plc
14 Apr 22
Shelf registration (foreign)
9:30pm
to the Relevant Agreements will at all relevant times remain, in compliance with all applicable anti-corruption, anti-money laundering, anti-terrorism
6-K
EX-5.1
AUTL
Autolus Therapeutics plc
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
is, and the Company and each party to the Sales Agreement will at all times remain, in compliance with all applicable anti-corruption, anti-money laundering
6-K
EX-5.1
1vekza 3k81afspo5pe
24 Jan 20
Autolus Announces Proposed Public Offering in the United States
4:06pm
8-K
EX-5.1
ah3c lc81qp
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
F-3
EX-5.1
7u2war61kv6lw ejb4
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
EX-5.1
xoydkjvz5 y8sv
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
S-3ASR
EX-5.1
h0gdn
7 Feb 24
Automatic shelf registration
10:00pm
6-K
EX-5.1
hlh3t3 2tsp
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K
EX-1
850 errlnztm4u
15 Mar 19
Annual Report and Accounts
5:26pm
10-K
1y1 tjtmc0lrq5m6
21 Mar 24
Annual report
4:55pm
F-1
32y mhdgyjmd4r5kyft
7 May 18
Registration statement (foreign)
4:45pm
F-1/A
xlhun2f n45n5h
19 Jun 18
Registration statement (foreign) (amended)
8:05am
6-K
EX-1
9pk1 6s97
30 Jun 21
Annual Report and Accounts
6:05am
F-1/A
gep1u4rjradnycy021
8 Jun 18
Registration statement (foreign) (amended)
6:25am
20-F
3b4djpjoq7k9un
23 Nov 18
Annual report (foreign)
12:00am